Biocon gains on stake sale in research unit to Silver Leaf Oak
The stock up 2.5% at Rs 512 on National Stock Exchange.
SI Reporter Mumbai Biocon is trading higher by 2.5% at Rs 512, after the biotechnology firm said Silver Leaf Oak acquires 10% stake in Syngene International, the company’s research services subsidiary.
Silver Leaf Oak (Mauritius), an investment vehicle advised by India Value Fund Advisors (IVFA), has agreed to acquire a minority 10% stake in Syngene, the research services subsidiary of Biocon, the company said in a statement.
Silver Leaf will acquire the stake from Biocon Research, a wholly owned subsidiary of Biocon at a valuation of Rs 380 crore, it added.
Post the completion of this transaction, Biocon and Biocon Research will jointly hold 85.54% stake in Syngene.
The stock opened at Rs 512 and hit a high of Rs 515 on NSE. A combined 540,000 shares changed hands on the counter in early morning deals on NSE and BSE.